Company profile
CS Diagnostics Corp.
OTC: CSDX · Healthcare · Medical - Devices
PublicHQ Cheyenne, CIK 0001106861Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 39
v0.1 · 5/100 weight · pillars only
↑ Altman-Z, listing tenure · ↓ workforce scale, filing timeliness
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
-100.0%
Net income (FY)
—
Employees
1
as of 2026-09-01
Market cap
$2.6M
as of 2026-09-01
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is CS Diagnostics Corp.’s financial profile?
CS Diagnostics Corp. has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
Cann American Corp.——FibroBiologics, Inc. Common Stock——Mid-Atlantic Home Health Network, Inc.——CYduct Diagnostics, Inc.——Strainsforpains, Inc.——Enzolytics Inc.——Key facts
CEOThomas Fahrhoefer
SectorHealthcare
IndustryMedical - Devices
HeadquartersCheyenne, null
ExchangeOTC: CSDX
Employees1
IPO date2005-02-17
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.